Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: Consensus from the Canadian conference on diagnosis of dementia

Alzheimer's Research and Therapy

Volumn 5, Issue SUPPL. 1, 2013, Pages

  Chertkow, Howard ^a,b   Feldman, Howard H ^c   Jacova, Claudia ^c   Massoud, Fadi ^d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; CANADA; CLINICAL PRACTICE; CLINICAL RESEARCH; COGNITIVE DEFECT; CONFERENCE PAPER; CONSENSUS; DEMENTIA; FUNCTIONAL DISEASE; HUMAN; MEDICAL SOCIETY; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PRODROMAL SYMPTOM;

EID: 84880174238     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt198     Document Type: Conference Paper

References (35)

1. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH, Alzheimers Dement 2011 7 263 269 10.1016/j.jalz.2011.03.005 21514250
2. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH, Alzheimers Dement 2011 7 270 279 10.1016/j.jalz.2011.03.008 21514249
3. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH, Alzheimers Dement 2011 7 280 292 10.1016/j.jalz.2011.03. 003 21514248
4. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P, Lancet Neurol 2007 6 734 746 10.1016/S1474-4422(07)70178-3 17616482 (Pubitemid 47058377)
5. Revising the definition of Alzheimer's disease: a new lexicon. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P, Lancet Neurol 2010 9 1118 1127 10.1016/S1474-4422(10) 70223-4 20934914
6. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Jack CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC, Alzheimer's Disease Neuroimaging Initiative, Brain 2009 132 1355 1365 10.1093/brain/awp062 19339253
7. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ, Lancet Neurol 2010 9 119 128 10.1016/S1474-4422(09)70299-6 20083042
8. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council; Council on Epidemiology and Prevention; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia, Stroke 2011 42 2672 2713 10.1161/STR.0b013e3182299496 21778438
9. The Clinical Dementia Rating (CDR): current version and scoring rules. Morris JC, Neurology 1993 43 2412 2414 8232972 (Pubitemid 23346995)
10. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H, J Am Geriatr Soc 2005 53 695 699 10.1111/j.1532-5415.2005.53221.x 15817019 (Pubitemid 41623495)
11. American Psychological Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed.: DSM-IV Washington, DC: American Psychological Association 4 1994
12. American Psychological Association, Text Revision of the Diagnostic and Statistical Manual of Mental Disorders, 4th ed.: DSM-IV-TR Washington, DC: American Psychological Association 2000
13. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC, J Intern Med 2004 256 240 246 10.1111/j.1365-2796.2004.01380.x 15324367 (Pubitemid 39222993)
14. Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Lopez OL, Becker JT, Klunk W, Saxton J, Hamilton RL, Kaufer DI, Sweet RA, Cidis Meltzer C, Wisniewski S, Kamboh MI, DeKosky ST, Neurology 2000 55 1854 1862 10.1212/WNL.55.12.1854 11134385 (Pubitemid 32103968)
15. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Feldman H, Levy AR, Hsiung GY, Peters KR, Donald A, Black SE, Bouchard RW, Gauthier SG, Guzman DA, Hogan DB, Kertesz A, Rockwood K, ACCORD Study Group, Neuroepidemiology 2003 22 265 274 10.1159/000071189 12902621 (Pubitemid 36993907)
16. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Neurology 1984 34 939 944 10.1212/WNL.34.7.939 6610841 (Pubitemid 14076461)
17. Early Alzheimer's disease. Mayeux R, N Engl J Med 2010 362 2194 2201 10.1056/NEJMcp0910236 20558370
18. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, Fox JH, Cochran EJ, Arends D, Treinkman AD, Wilson RS, Neuroepidemiology 2006 27 169 176 10.1159/000096129 17035694 (Pubitemid 44651437)
19. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Morris JC, Arch Neurol 2012 69 700 708 22312163
20. Cerebral amyloid deposition and diffuse plaques in 'normal' aging: evidence for presymptomatic and very mild Alzheimer's disease. Morris JC, Storandt M, McKeel DW Jr, Rubin EH, Price JL, Grant EA, Berg L, Neurology 1996 46 707 719 10.1212/WNL.46.3.707 8618671
21. [§ssup§11§esup§C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Neurology 2006 67 446 452 10.1212/01.wnl.0000228230.26044.a4 16894106 (Pubitemid 44214969)
22. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al. Neurology 1993 43 250 260 10.1212/WNL.43.2.250 8094895 (Pubitemid 23060253)
23. Vascular cognitive impairment. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST, Lancet Neurol 2003 2 89 98 10.1016/S1474-4422(03)00305-3 12849265 (Pubitemid 37443329)
24. Management of dementia with a cerebrovascular component. Bocti C, Black SE, Frank C, Alzheimer Dement 2007 3 398 403 10.1016/j.jalz.2007.07.009 (Pubitemid 47541949)
25. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R, Neurology 1992 42 3 Pt 1 473 480 1549205
26. The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. Rockwood K, Davis H, MacKnight C, Vandorpe R, Gauthier S, Guzman A, Montgomery P, Black S, Hogan DB, Kertesz A, Bouchard R, Feldman H, Can J Neurol Sci 2003 30 237 243 12945949 (Pubitemid 37064520)
27. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Gold G, Bouras C, Canuto A, Bergallo MF, Herrmann FR, Hof PR, Mayor PA, Michel JP, Giannakopoulos P, Am J Psychiatry 2002 159 82 87 10.1176/appi.ajp.159.1.82 11772694 (Pubitemid 41070731)
28. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Holmes C, Cairns N, Lantos P, Mann A, Br J Psychiatry 1999 174 45 50 10.1192/bjp.174.1.45 10211150 (Pubitemid 29037883)
29. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC, Neurology 2001 56 1143 1153 10.1212/WNL.56.9.1143 11342678 (Pubitemid 32405708)
30. Observations on the brains of demented old people. Tomlinson BE, Blessed G, Roth M, J Neurol Sci 1970 11 205 242 10.1016/0022-510X(70)90063-8 5505685
31. Preventable senility: a call for action against the vascular dementias. Hachinski V, Lancet 1992 340 645 648 10.1016/0140-6736(92)92177-H 1355217
32. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC, Brain 2007 130 2837 2844 10.1093/brain/awm238 17928318 (Pubitemid 350033975)
33. A life course approach to cognitive reserve: a model for cognitive aging and development? Richards M, Deary IJ, Ann Neurol 2005 58 617 622 10.1002/ana.20637 16178025 (Pubitemid 41377226)
34. Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge City over-75s Cohort (CC75C) Study. Brayne C, Richardson K, Matthews FE, Fleming J, Hunter S, Xuereb JH, Paykel E, Mukaetova-Ladinska EB, Huppert FA, O'Sullivan A, Dening T, Cambridge City Over-75s Cohort Cc75c Study Neuropathology Collaboration, J Alzheimers Dis 2009 18 645 658 19661624
35. What do we mean by Alzheimer's disease? Richards M, Brayne C, BMJ 2010 341 4670 10.1136/bmj.c4670 20940218 Dementia